double and will outpace the overall population growth rate, given the distribution shift toward older adults. Furthermore, by 2060, the number of people with a moderate or greater hearing loss will exceed the number of people who have a mild loss today.
2 A recent NASEM report 1 made recommendations to improve access to interventions and hearing health care services. However, these recommendations need to be approached by policy makers in the context of the expected rapid growth in the number of individuals with hearing loss during the next several decades. The increased need for affordable interventions and accessibility to trained hearing specialists will require novel and costeffective approaches to audiologic health care. One limitation of the present study is the assumption that current prevalence rates of hearing loss by age decade 2 will remain relatively constant during the next 40 years and beyond. This assumption is reasonable given that the primary risk factors for acquired (noncongenital) ). Given the projected increase in the number of people with hearing loss that may strain future resources, greater attention to primary (reducing incidence of hearing loss), secondary (reducing progression of hearing loss), and tertiary (treating hearing loss to reduce functional sequelae) prevention strategies is needed to address this major public health issue. , 1959 -1962 and 1999 -2004 . Ear Hear. 2010 31(6) :725-734.
Survival Outcomes in Oropharyngeal Small-Cell Carcinoma Compared With Squamous Cell Carcinoma: A Population-Based Study
Small-cell carcinoma (SmCC) is a neuroendocrine malignant neoplasm that usually occurs in the lungs. Oropharyngeal SmCC is a rare entity, with the current literature limited to case reports and small case series. Many of these reports suggest that it is a highly aggressive disease with dismal outcomes. [1] [2] [3] [4] [5] [6] However, it is difficult to draw conclusions about the survival outcomes of oropharyngeal SmCC based on the existing literature. The goal of our study was to evaluate the survival outcomes of oropharyngeal SmCC, compared with squamous cell carcinoma (SqCC).
Methods | This study was exempt from review by the Stanford University Institutional Review Board due to its use of deidentified public data. The study cohort included adult patients who received a diagnosis of oropharyngeal SmCC or SqCC between 1973 and 2013, identified in the Surveillance, Epidemiology, and End Results (SEER) 18 Database. Disease stage was recorded using SEER historic stage, classified into the following: "localized," "regional," and "distant." Race was recorded in the SEER database as "white," "black," or "other."
The SEER computer software (SEER*Stat, version 8.3.2) was used to extract data from the SEER database and to compute disease incidence. The statistical analysis was performed using IBM SPSS, version 23 (IBM). Survival analysis was performed using Kaplan-Meier analysis. The outcome variables were overall cumulative survival (OS) and diseasespecific cumulative survival (DSS). A Cox proportional hazards regression model was used for multivariable analysis. Candidate covariates were entered a priori into the model. An estimate was considered statistically significant at α = .05.
Results | The SEER database identified 45 patients with oropharyngeal SmCC, compared with 40 571 patients with SqCC.
Letters
The incidence of oropharyngeal SmCC was 0.003 per 100 000. Patient characteristics are shown in the Table. Patients with oropharyngeal SmCC were more likely to present with distant disease (odds ratio, 3.76; 95% CI, 2.04-6.96) and less likely to present with regional disease (odds ratio, 0.34; 95% CI, 0.18-0.62).
Small-cell carcinoma was associated with worse OS (5-year OS, 19.5% vs 49.5%; difference, 30.0%; 95% CI, 17.1%-42.9%) and DSS (5-year DSS, 24.1% vs 58.3%; difference, 34.2%; 95% CI, 19.1%-49.3%) compared with SqCC ( Figure) . On multivariable analysis, SmCC was associated with worse OS (hazard ratio, 1.67; 95% CI, 1.02-2.73) and DSS (hazard ratio, 1.80; 95% CI, 1.06-3.03), after adjustment for age, sex, race, year of diagnosis, site, distant disease, regional disease, surgical resection of primary site, treatment with neck dissection, radiation therapy, and lack of treatment. Discussion | To our knowledge, this study is the largest study to date of patients with oropharyngeal SmCC. We show that oropharyngeal SmCC was more likely to present with distant disease, less likely to present with regional disease, and was associated with poor OS and DSS, compared with oropharyngeal SqCC. Given the rarity of the disease, the literature on oropharyngeal SmCC is mostly limited to case reports and small case series. The earliest documented case series comes from a single institution's 24-year experience published in 1972.
1 All 5 patients died of disease, with a follow-up of 5 to 180 months. Bishop and Westra 2 published the largest series of primary oropharyngeal SmCC, with 9 cases. Seven of the 9 patients died of disease, while the remaining 2 showed no evidence of disease at 5 and 20 months of follow-up. Another relatively large case series by Kraft et al 3 reported on 8 patients with oropharyngeal SmCC. Of the 6 patients with available clinical data, only 1 patient remained disease-free at 25 months follow-up. The poor outcomes for SmCC suggest the need for more aggressive therapy in this type of oropharyngeal cancer, Patients with small-cell carcinoma had worse survival than patients with squamous cell carcinoma. Report of a Case | A man in his 40s with untreated CML and hepatitis C presented after a fall. He had right-sided hearing loss, positional vertigo, and a right beating nystagmus that increased with right lateral gaze. Admitting laboratory examination showed white blood cell count (WBC) of 697 120/μL (blasts, 3%). Peripheral blood smear results were consistent with chronic phase CML, not in blast crisis. He was treated with plasmapheresis and a tyrosine kinase inhibitor. Computed tomography (CT) scan of the head showed intracranial arterial radiodensities consistent with leukocytosis. Magnetic resonance imaging (MRI) showed chronic, hemorrhagic appearing lesions in the cerebellum, brainstem, and left occipital lobe. On hospital day 3, his hearing declined on the left side. His spontaneous right beating nystagmus had resolved but head impulse testing (HIT) results identified a refixation saccade for the right horizontal semicircular canal (SCC). Several days later, HIT results showed bilateral horizontal SCC hypofunction with overt compensatory saccades. Otoacoustic emissions, acoustic reflexes, and bilateral caloric responses were absent. Pure tone audiometry showed a bilateral profound SNHL. Review of admitting T1-weighted MRI postgadolinium axial scan results demonstrated hyperintensity in bilateral labyrinths (Figure 1 ). While aided with behind-the-ear hearing aids, he scored 0% on AzBio test sentences in quiet at 60 decibels (dB) sound pressure level and received a left cochlear implant. Six months after implantation, his left ear improved to 88% in quiet and 36% in +8 dB SNR (Figure 2) .
Since discharge, he has been followed by a vestibular rehabilitation specialist and practicing home vestibular exercises. At 1 year, he had evidence of central nystagmus, 
